Literature DB >> 11668146

Lactulose may help prevent urinary tract infections.

M Battle, T Martin, J Fulton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11668146      PMCID： PMC1121453          DOI： 10.1136/bmj.323.7318.936

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.

Authors:  T Kontiokari; K Sundqvist; M Nuutinen; T Pokka; M Koskela; M Uhari
Journal:  BMJ       Date:  2001-06-30

2.  The effect of lactulose on the faecal flora of patients with hepatic encephalopathy.

Authors:  A Vince; R Zeegen; J E Drinkwater; F O'Grady; A M Dawson
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

3.  Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care.

Authors:  J McCutcheon; J D Fulton
Journal:  J Hosp Infect       Date:  1989-01       Impact factor: 3.926

4.  Lactulose--a drug with antiendotoxin effect.

Authors:  H Liehr; G Englisch; U Rasenack
Journal:  Hepatogastroenterology       Date:  1980-10
  4 in total
  3 in total

Review 1.  Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases.

Authors:  Andrew Szilagyi
Journal:  Nutrients       Date:  2015-08-13       Impact factor: 5.717

2.  The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial.

Authors:  Hamid Tayebi-Khosroshahi; Afshin Habibzadeh; Bahram Niknafs; Reza Ghotaslou; Fatemeh Yeganeh Sefidan; Morteza Ghojazadeh; Majid Moghaddaszadeh; Sahar Parkhide
Journal:  J Renal Inj Prev       Date:  2016-07-29

3.  Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study.

Authors:  Sandra Y Wotzka; Markus Kreuzer; Lisa Maier; Mirjam Zünd; Markus Schlumberger; Bidong Nguyen; Mark Fox; Daniel Pohl; Henriette Heinrich; Gerhard Rogler; Luc Biedermann; Michael Scharl; Shinichi Sunagawa; Wolf-Dietrich Hardt; Benjamin Misselwitz
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.